 SelectQuote (NYSE:SLQT – Get Free Report) is expected to announce its  Q1 2026 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $323.6820 million for the quarter.  SelectQuote has set its FY 2026 guidance at  EPS.Individuals can check  the company’s upcoming Q1 2026 earningsummary page for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:30 AM ET.
SelectQuote (NYSE:SLQT – Get Free Report) is expected to announce its  Q1 2026 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $323.6820 million for the quarter.  SelectQuote has set its FY 2026 guidance at  EPS.Individuals can check  the company’s upcoming Q1 2026 earningsummary page for the latest details on the call scheduled for Thursday, November 6, 2025 at 8:30 AM ET. 
SelectQuote (NYSE:SLQT – Get Free Report) last issued its quarterly earnings data on Thursday, August 21st. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.01. SelectQuote had a net margin of 3.12% and a return on equity of 6.35%. The company had revenue of $345.10 million for the quarter, compared to analysts’ expectations of $334.09 million. On average, analysts expect SelectQuote to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
SelectQuote Price Performance
Shares of NYSE SLQT opened at $2.11 on Thursday. The company has a current ratio of 5.68, a quick ratio of 5.68 and a debt-to-equity ratio of 0.90. SelectQuote has a 1-year low of $1.62 and a 1-year high of $6.86. The firm has a market capitalization of $370.23 million, a P/E ratio of 42.10 and a beta of 1.30. The firm’s 50-day moving average price is $2.09 and its 200-day moving average price is $2.26.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several analysts have recently weighed in on the stock. Royal Bank Of Canada lowered their price objective on shares of SelectQuote from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research report on Tuesday, August 5th. Zacks Research raised shares of SelectQuote from a “strong sell” rating to a “hold” rating in a report on Wednesday, October 22nd. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of SelectQuote in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.38.
View Our Latest Research Report on SLQT
SelectQuote Company Profile
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Read More
- Five stocks we like better than SelectQuote
- ESG Stocks, What Investors Should Know
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- Energy and Oil Stocks Explained
- Verizon Results Trigger Rebound in High-Yield Stock
- What is a support level?
- Picks & Shovels: Investing in the Physical Foundation of AI
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.

 
						